Projects
![]()
No projects found
Investors
New
DAO Treasuries
DATs
Lend / Borrow APRs
Chains
Categories
Spaces
DeSci Office Hours
Recorded: July 28, 2025 Duration: 1:03:39Space Recording
Short Summary
Pump Science is set to launch its first token cohort on July 29th, integrating health supplements with blockchain technology to enhance longevity. The project aims to revolutionize the supplement industry by leveraging empirical data and fostering partnerships with supplement companies, signaling a significant trend in the intersection of health and crypto.
Full Transcription
hello hello what's up buddy doing good how are you good a little bit of outside the podcast
uh info for everybody kiho and i were on another meeting right before this and
uh virtually ran
to get here to be able to talk to you all.
So we're a little out of breath, but we're happy
to be here. Happy Monday.
Happy Monday to everyone.
Sorry, I'm
picking up an echo.
Yeah, you sound futuristic
today. Really?
Yeah. Beep boop. Is it with my mic?
Yeah.
Okay.
Let me come back from my personal account.
Okay, no worries.
We'll hang out. There goes microbiome down.
There goes microbiome down.
It's hard running multiple accounts, Kehoe.
I know how it feels.
You think you're on your personal, but you're on your representative account.
Can I get you to be a co-host too?
Okay.
You with us? Am I with us still? That's the question.
Hi, can you hear me?
Yeah, you sound great, Ben.
Awesome. Yeah.
All right, guys. GM GM, welcome to late night or late night DCI office hours today. We are late.
Better late than never. Exactly. Yes. Today we have an interesting, you know, update and more sort of an alpha to discuss.
Interesting, you know, update and more sort of an alpha to discuss.
We are going to go into the DGEN territory of DCI,
getting into meme coins from pump signs,
but this is not your average meme coin.
it's your buy-in into longevity right um carlin um carlin is our drug dev from
It's your buy-in into longevity, right?
pump science uh let's listen it from carlin what pump science is cooking and uh how this could
really change the uh you know arena of uh dsai because i think it really changed a lot of narrative around d sci
and what sort of revolution are you guys cooking these days absolutely welcome to the new scientific
revolution the sort of you know what's taking science from something that's run by like experts or you know by people who have you know years and
years of stuffy um sort of you know elitism under their belts in order to actually decide what is
and isn't right for you know human consumption um and so pump science you've all heard probably at
this point that meme coins are you know that maybe they're dead. Some people are saying this. But pump science is sort of bringing the utility back to meme coins.
that humans as a society, we're growing older with each year. We're able to live longer these
days. But unfortunately, I think a lot of the time, living longer doesn't necessarily coincide
with, you know, improvement of your health span, you know, the ability to move autonomously,
move on your own, do the things that you want to do later into your life. And so pump science sort of has come along
as a way to efficiently and, you know, more effectively and with a higher sort of throughput
effect to test different compounds for their ability to expand your longevity, increase your
lifespan, improve your overall health. And so they're doing
this through various supplements. And each of the supplements is sort of represented or like
a combination of supplements is included as a token that is launched from the Pump Science
Launchpad. And I think that starting tomorrow, Tuesday, July 29th at 8 Eastern Standard Time.
The first sort of like cohort of launches will be going off.
I'll be launching one of them.
I am the drug dev for the combination treatment of Berberin, which is a very, it's a metabolic regulator. It's a super bitter
sort of supplement that is able, has been shown to sort of reduce like gut inflammation,
really help with the activation of AMPK and making sure that sort of like all of our metabolic and anti-inflammatory functions
are functioning properly. In combination with berberine, I'm going to be testing what happens
when you also use biotin as a treatment. So biotin is vitamin B7, I believe. It's a coenzyme.
It's really known for its ability to increase energy efficiency. So whereas we're
sort of like getting our metabolism right with the, you know, the berberin of it all,
we're now using biotin to hopefully make sure that the energy that we need to function in these
newly cleared out sort of metabolic spaces is activating on
all cylinders. So, you know, hopefully through this combined, nobody's really looked at these
when looked at together. And that's the thing that pump science is really, I think the strongest
point of pump science is that it's a way to test all these things that already exist that have not
been looked at in a longevity sense. And, you know, we maybe have
seen one-offs of a lot of these, like, I think one of them is NAD plus that's going to be on the
site. And, you know, not necessarily the rigor or, you know, the scientific, yeah, scientific rigor
that you would want in order to make specific claims on, you know,
the ability of these compounds. So yeah, it's sort of a small breakdown of what's going to be
happening. You know, I'm here to talk about anything, any questions for me, Kiyo?
Yeah, definitely. So right up, I have some questions around this.
I have some questions around this.
You're setting an experiment to test a couple of these compounds.
Seems to have a lot of evidence to be used as a supplement in the general market.
A lot of people are consuming.
Even I'm considering to try Berberine after you pitched it.
I'm going through the internet to figure out you know
it's in the end of the card yeah absolutely but but like my question is towards what sort of
experiments are you guys gonna run like I know like you guys gonna experiment it on different
animal models but can you walk us through like what is the relevance behind each of these models
and why do you guys would do such experiment and what does it prove about that particular
compound?
Yeah, that's a great question.
So the sort of like protocol for pump science is tiered.
So with each, you know, as you accrue more trading fees, as more of the token a very, very commonly used sort of longevity
model organism because they have a pretty short lifespan. And so I don't know off the top of my
head exactly how long C. elegans are supposed to live or in, you know, in the wild would live.
But basically, the worms are then fed a diet containing the compounds that you're testing.
The worms are then fed a diet containing the compounds that you're testing.
And then they will be, while they're being fed this, they're sort of monitored for any general toxicity.
Because at any point in the experiment, if your compounds prove to have like a negative effect on health, they are less likely to be, they're probably not going to be moved to the next stage because we don't
want to be, you know, putting even these model organisms through like unnecessary like pain.
But the thing is that, you know, they'll then look at these worms to see if they're able to
in any way extend the lifespan. And then beyond worms, you then go to, you know, what's the next sort of like
complex organism that's not yet getting into like our mammalian stuff. We're then looking at
flies. So Drosophila melanogaster, they're fruit flies. They similarly have a pretty
short lifespan compared to, you know, other models that you can use. And, you know,
there's a little bit more similarities between us and flies than some people would like to admit.
So in some ways, you're probably able to tell, you know, based on like the dosing and the
different things like that, if feeding them these compounds also increases their lifespan.
What's interesting about the fly experiments is
that they also have a fly taxiing. So fly races, you can, they do sort of on pump.science,
they have these really cool like F1 based, so F1Y fly races. If you're into that sort of thing,
where they sort of like do a taxiing experiment.
And the taxiing experiment is where you take the tube that all the flies are in,
you shake that and you like slam them down on the table so that all the flies are sort of like shot to the bottom.
And then you want to see how fast those flies are able to climb back up to sort of like the top where the food sources are in the tube.
to sort of like the top where the food sources are in the tube.
And that's a pretty interesting and fun way to sort of like further gamify the experimentation.
And then, you know, beyond the fees that you accrue for the flies,
if you then unlock the next level, you also are able to test them in mice.
So I think a lot of us know that mice are the model organism that you definitely
need studies in before you're able to move to any sort of like clinical trial. If you to be tested
in humans, I think with supplements, it's a little bit more relaxed. So as long as you can
show that they're not toxic to, to the things that you're testing. You're able to sort of like skirt around the human testing requirements in that way.
And then the mice experiment, since they live a little bit longer and, you know, in crypto,
two years is essentially a thousand years.
You really need to, you know, keep people's attention for over an extended period of time.
So what they've done there is the they do more of an endurance test.
So these mice are fed whatever these compounds may be.
And then after a sustained amount of time in the end, they're definitely like older aging mice. So we can see sort of like how these supplements can help maybe people that are entering into like the later years of their life to, you know, better be able to walk longer, you know, enjoy the outdoors and things.
And so these mice are fed these sort of compounds in addition to their extra food.
And then they're put on a thing called a rotor rod. And so these
were things that if you check pump sciences page, they're called the radio. So literally like a
spinning rod, the mice are put on it and it continues to spin and speed up over time. And
what's tested is how long the mice are able to actually last by running on these rods.
actually last by running on these rods. And then that's sort of the model organism
route. One thing that's maybe not often is discussed because it's still in the works is
that Pump Science has a partnership with Pulse, a wearable company that sort of has, you know,
a lot of the biomarkers or markers that we look at for, you know, cardio health,
heart health, those sort of things. And anybody can sort of like enter into these,
quote unquote, human trials to, you know, say like, hey, I'm using such and such compounds,
you can use my data to analyze and see how they're affecting sort of the performance of my body on a day-to-day
basis. And I think that's still in the works because the Pulse actual physical wearables are
not yet out. But I think I know with the existing Compound Zero and Rift, those are already an
existing sort of like partnership they have going. i think that you know for these future things that are launching that's also an option that's available
which is pretty exciting
that's a good question to you now those uh taxis you know like uh um fly taxi i want to see those
experiments running uh it's gonna be fun uh but like more towards the the science side of it
with pumped out science i i just have a question because because you can find these supplements
already in the market so that means people are consuming it and it's not toxic uh at least to
a certain group and uh how this you know this sort of trials are gonna add more sort of data on top of
this particular compound because at the end it's gonna be the supplement companies who are selling
burburins gonna make profit out of it if you guys make those data to you know really help them product sale goes up
and how could this translate to those you know uh meme coin holders like the the cult which is
pushing those projects or the drug devs who are pushing those projects do you guys have any
partnerships in place or do you guys you know um really put put the data open or like you will then plan to really, you know, patent this data and then provide those insights to the supplement companies?
But then my question is more towards the science, whether this data that you guys are generating is enough to create that momentum for the compound?
Or is it going in the right direction like is this the
data that we need to really push this compound or what's the intention behind you know the rotor
rod experiment taxi and all of that how does this would change perspective of how people see berberin
or biotin yeah so i think i'll get at your first question a little bit.
With the partnerships, you know, I think right now,
it's sort of up to each individual drug developer,
like what partnerships they enter into.
And so I, as a drug dev have sort of
decided that once the token launches, I want to do sort of community sourcing. So I want the
community to sort of decide which is the, you know, best formulation and best, you know,
supplement sort of partner to go with, you know, if they are the ones that are the most
invested in this, in these compounds for longevity, then I want the people that, you know,
participate and contribute to the experiments to be the ones that are deciding like where they'd
like to get their, you know, their different compounds from. And this
could maybe include, you know, finding out the right formulation that everybody likes to use
the most, and then partnering with a general manufacturer to then put that on, you know,
the general like pump science supplement website, if they that they have. And that could also be, you know, it could involve just,
you know, partnering with existing like nature's bounty sort of things. I don't know if they would
necessarily be interested, but it's at least worth reaching out to, you know, be like, hey,
out to, you know, be like, hey, we have this now, like, very, very uniform and controlled data
that shows that with, you know, some significant results, this such and such combination leads to
this, and sort of, you know, representing it almost as if it's a licensing agreement for these different producers.
And so I hope in that way that it would lead to a little bit more value going back to the people
that committed to getting these experiments right. But I, it's a little too early to tell how that is actually going to go.
I think the, at least the main purpose and the, and as we can see it, the goal for pump science
right now is to, you know, find out what works and what doesn't, you know, and then, you know,
once we get what works and what actually doesn't, instead of a lot of anecdotal stuff, we have empirical data that makes sense and is statistically relevant to a vast majority of people.
Then we can get into what it says for any of the general like supplement makers. But I think that it would,
you know, stand to reason that we could then get to a point where everybody, every supplement that
would, you know, want to come to markets finds its way through pump science, we can maybe get
to a point where you need the pump science approved sticker on your, on your like, supplement,
your vitamin bottle or whatever before you decide
that it's actually, you know, what it says it is. Because, you know, the a lot of these things
already exist. But like I said, the, the new value that the pump science experiments are adding
are the, you know, the different formulations, the, the experimental rigor, and the, you know, the ability to sort of,
like, actually look at the data yourself as a citizen to understand what you're looking at
before you buy. And then, you know, we can hope that people make the decision that is not just
the most convenient for them, but the one that is, you know, the right decision for them to,
you know, purchase their supplements going forward.
Does that kind of answer your question, Kehoe?
It does. I'm just like going around because, see, from my perspective, I have, I can really order this supplement right now and have it.
I can really order this supplement right now and have it.
But then what this model would like, you know,
participating in pump science would really give me is that sort of data to
back my effort, right?
Like back those bases on why I should take Berbidin.
It's not just because Google say so or the supplement company say so.
Yeah, because of the theoretical, you know, cellular benefits that you get.
You know, nobody gets, feels better at a cellular level.
They feel better at a tissue and an organ level, you know.
More like a monk.
Yeah, yeah.
Yeah, understanding, you know, the holistic effects
as opposed to just a specific you know experimental mechanism we
want to see what the actual downstream effect is all right uh would you then like if you have some
initial evidences on a particular compound can you skip models and go directly to mice model and
then to humans is that possible uh not that i'm aware. I think that you, you know, you can maybe set out to your community that you have a fundraising goal that, you know, is higher than an initial raise for some of the like fair launched tokens.
Because, you know, once the initial platform is live, you can sort of take whatever route you want to launch your compound token.
take it whatever route you want to launch, to launch your, um, your compound token. Um,
but there is like a, uh, a form that you would need to fill out in order to actually launch it.
And I think through that, that triggers then the, the worm experiments. Um, and so there is sort of
the stepwise, um, stepwise way to go about it. Um, there may be a case in the future where things
have maybe already been
tested in, you know, the worms and the flies, and we're doing like an updated raise for,
to do like a different dose or something like that. And maybe then those can be
taken straight to the mouse experiments. But I think, you know, just for consistency's sake,
it is important to go from the least complex to the more complex organism in this case.
And it's more fun to level up, you know what I'm saying? You don't want to start out at level 15
or level 20. You want to see what it's like to go from level one to level 10 you know it's more fun to to level
up and so pump science is like leveling up science i would i would tell people awesome so let's say
like theoretically um or hypothetically if if you are uh if if berberin like you know or any compound
goes through the my study with uh flying colors uh what's gonna happen next
it's just for me to see like will there be an exit for me
yeah for sure i think that you know a part of the the like platform is once there is a more, I think right now we don't necessarily have an exact
output or a, you know, best standard practice output for the mouse studies.
And so I think once that is more developed and we now have a very clear, like this makes mice live longer. I think I would then see if, um, for maybe first
doing like a more complex mammal. Uh, so like maybe we could then level up to, um, uh, what's
a, what's a more complex my mouse, uh, we could do, you know, uh, this is far reaching, but like
a primate study, you know, non-human primates are very similar to, to humans and a lot of their genetic makeup.
Um, and so that would be, that would be an interesting followup, but, you know,
like we said with supplements, it's really, really not regulated. And so I think from the,
um, the mouse experiments, if there's a very clear increase in, you know, endurance and stuff like
that, we can then at least market these compounds as things that enhance your endurance and improve
your health span. But I think that it's still a little early for a clear output for longevity in these more like longer living models. And so I
think maybe also with the like longitudinal studies that we could carry out with the humans,
we would then have a little bit more of a like, a better idea. So I think long term,
it's the human studies, but in the term we could do more complex more complex animals
that might be a like a community-based decision I think going forward but as long as you are
improving in mice then it's like I think that's plenty enough evidence for a lot of people that
it is something that could improve your health as a human.
Awesome.
A follow-up question, perhaps.
Now you guys are focusing on longevity.
Let's say I want to focus on something else.
For me, what is interesting is looking at the gut.
So it's also non-invasive.
You just take poop and try something.
Or you can also try some mental experiment, right?
Like cognitive function and stuff like that.
So is it in the plan to expand just beyond a rotor rod and put some rods on these, rods on the, you know, these mice brains and see how
they react because I was seeing one of those interesting projects where they connected
a mice to an AI system, like an augmented mice with a computer on its head, which is
connected to a real-time AI and in a fundraise going on for this project,
I think it's very successful.
So I'm just curious to see, like,
is this something in the plan for pump science
to go beyond Rotterot, you know, longevity trials
and going more into the sort of, you know,
yeah, other areas of health?
Yeah, I think so. I think the more endpoints that we have, you know, the more data that we can
gather from what these compounds are doing to not only the physical, but the mental health. I think
that's another part of healthspan that's maybe largely ignored is that, you know, the mind often goes before the body goes. And so it would, and a little like funny
story during the first rotor rod, the like firstIF, was shown to jump off of the rotor rod.
So it probably could have hung on for longer, but jumped off as soon as it started spinning.
And it did that after the first time and then continued to do it every time.
So there was a little bit of like a data, a data skewing and that kind of brought up in,
um, Benji and Jillian's heads, like, oh, is there maybe a mental aspect to, to taking
these compounds?
Like, is it, is it doing something to these mice's mental health?
Um, or like, you know, are they increasing in their ability to to comprehend and understand that
they you know maybe it doesn't want to have to run on this if it doesn't get any sort of like
benefit out of running for longer and so I think it would be really cool to to check out the I
I need you to send me this robot that's attached to a mouse for sure.
I want to see that.
It's called ratpithia.ai.
Pithia as in P-Y-P-H-I-A.
Yeah.
Right.
This is, you know, like I really looked at the project.
I don't know, like they call it dawn of homo sapiens 2.0
looking at it right now yeah yeah then i think this is really catchy right like uh something
like this but uh for fun science as well like you can see the um show physical 100 it's a korean
based reality show um where they where they do like a whole slew of,
they get people from different,
different physically impressive sort of like realms.
So like there's bodybuilders,
they're endurance athletes,
like marathon runners,
there's,
you know,
wrestlers and stuff like that.
And they put them through like a slew of physical challenges.
So like hanging from bars,
like rolling things. So I think that including not only the mental, but like more advanced or,
or, you know, things that test a little bit different levels of like, endurance and, you
know, strength and, you know, ability to, you know, focus on, you know, different aspects in these mice studies,
we can then not only get more data points, but also a better look, you know, with the
governance that comes with the tokens to sort of like help make decisions on what
experiments will be tested with each individual mouse. It's like, oh, maybe you think that berberine with resveratrol is specifically good for improving like your
endurance strength. So you then do the hanging test to see if they can hang longer. But you
think that berberine and biotin is better for, you know, things like coat and metabolism efficiency so then you can check the you know
you do like a little fashion show or a coat check for for uh these mice that are taking these things
to see like is it not just increasing endurance is it also you know doing any of the things that
i think people would associate with being a healthy individual so do you look good do you feel good do you perform
well that's really interesting so um as a small sidetrack specifically for berberan uh you say i
i'm seeing it's interesting only helps with a lot of digestive issues uh i want to see what sort of
i know you'd love it yeah i'm i love it already i want to see
like what sort of effect it has on gut so anyways you're gonna you know work with these um mice in
your uh in your rot rod experiments and all of that uh can you guys collect its poop and send it
to us like we we would like to see how this really affects their gut. Will that be an interesting experiment sort of collab?
Yo, that would be the perfect collab.
I might hit up the pump science people right now.
Let's get these poops gathered up.
That's a genius idea.
We could have a shit plan for that.
Yeah. That's interesting all right yeah yeah uh i had not thought about that that's so that's such
a good idea because specifically for berberine i just saw like a lot of evidence towards digestive
health and its molecular mechanism is towards you know, restoring the gut lining and something around this realm.
And spoiler alert, a lot of the compounds that are launching are combination treatments with berberine.
So it would even be really cool to see, like, are any of these creating like synergistic effects with berberine for the gut health specifically?
That would be sick.
It will be yeah yeah awesome awesome
all right uh so i while you were talking i heard government uh is it true uh are you guys giving
governance rights are you going into that path or is just a meme coin so i think it is mostly a
meme coin uh but it's up to each individual drug dev, sort of the route that their token
takes. So, you know, we're meme coins with utility. So I, in, you know, future iterations in an ideal
world would like to be able to consult the community. And, you know, right now they do it
with Riffin Euro whenever there's sort of a, you know, um, a question of whether to,
you know, do things like buy back and burn. Um, so I, I wouldn't see a problem with, you know,
maybe not, uh, total governance, but, you know, the governance votes, I think will still be very
important for, you know, deciding if, if maybe we maybe we finish our first set of experiments, because
my initial goal is to accrue enough fees to do all of the mouse, the fly, and the worm experiments.
And beyond that, you know, it's really like up to, I hope, the community to decide, you know, what the future
for these tokens are. Because, you know, once the Pump Science Protocol has run its course,
these tokens will still exist. And so I would like for, in an ideal realm, I'd like for the
community to continue to be engaged and, you know, help me with deciding what we should do with these two compounds. In the best case
scenario, they are the kings of the pill, the ones that show the most effectiveness in either
the worms or flies. And, you know, people continue to hold them because holding on to the kings of
the pill leads to accruing more rewards as, you know, different compounds get launched and they start
to stack up. But then, you know, in the worst case scenario, they're, they're probably like third,
I would guess, which, which is tough, because it shows that it's really effective, but it's not as
effective. And in that case, then it would just be sort of, you know, continuing to find ways to innovate and find the utility in these means because, you know, it's silly to let perfectly good compounds sit by the wayside when they could be working for us.
All right.
How will how will does these results coming out of my studies translate into human?
Like, because this I'm asking from the science perspective, you have been working into the models and all of that, specifically in developmental biology.
So that I can understand, right, like for each use cases, there could be models that are relevant but specifically for longevity mouse seems like a good model and the models
that you already have in place seems to be a good model. How does it translate to when it comes to
human because I think there is certain fail rate for studies that are done in mice and does not really replicate in human trials.
So just to get an understanding around that, not relating to prompt science, but in general.
Yeah, so I think that I can't remember the percentage exactly of how many things work in mice, but then failed in their first initial clinical trial in humans. It's probably close to like 90%, maybe more.
there, although there's a lot of like, you know, things at a genetic level or at a, you know,
you know, basic orthogonal physiology. So like, you know, we have fingers, we have toes,
that sort of thing. We have genes that sort of pattern our bodies in a similar way because we're
both vertebrates. There is sort of this, like I was saying, the like tissue and organ level of things that working that I feel that is not necessarily translated in the into the effectiveness in humans.
There's a lot of different reasons maybe for that.
There's the dosing.
It's hard to maybe scale the dosing for for mice versus humans.
There's the sort of scale of our lives. Mice don't live
nearly as long as we do, although they live for a few years. So I think that while mouse models
are still going to be a great use case for modeling disease, I think it's a great, it's a great way to model disease without sort of
doing human experimentation. The best way forward for things like the supplements and compounds is
for us to put ourselves on the table. So, you know, we, we want the evidence of the,
the mice in the, in these other model organisms, because it provides confidence for the, you know,
people that might invest in these compounds that, oh, the due diligence has been done. And this,
this is something that has been studied and has an effect in a way that is deemed significant.
But until we see sort of these other than, you know, maybe like generational sort of looks for mice, because
we can, you know, continue to, we can maybe treat a whole family with a certain compound through
their entire lifetime to see how that goes. But I think we won't really know for certain until
we have these, you know, humans that are willing to put their, you know, see things that
work for them and continue to test them and see, put their own, you know, selves under the microscope
to show like, this worked for me, and here's my genetic makeup. And here's what I do in a day.
And here's how it helped me. And then people, you know, people can then take that data, which I hope will be made openly
available through these studies to then, you know, work backwards to actual, you know, the mechanistic,
what's truly going on mechanistically to like help these things as lifespan improvers.
so yeah it's long long answer of what say a way of saying um i think that the mice are important for
um the what is it validity of things but for the effectiveness we won't really know until
we actually do human testing. Makes sense.
So then this could already be like, you know,
I see like this could evolve in a way that people who are interested in,
let's say, this particular combo of berber and biotin or any certain combo,
they can then go in and be the participants themselves if the evidence kind of
convince them to, you know, really take this to the next step and test these supplements at a
certain combination and see how it works and they can report their interesting findings.
Yeah, exactly. Like more citizen science approach too. Exactly. Getting more of the people
involved. We all do science every single day. We just don't know it and we just don't recognize it.
So, you know, the more people that we can get to engage, I think the better.
I really love that. I think people need some source of contact, like an app or a device or something that, you know, like where you can get in touch with or get this up and running.
like who are kind of doing these experiments at a small scale,
n is equal to one, could then like, you know,
come together and build that number considerably,
testing a bunch of different trials.
I think that would be a great vision ahead,
not just for science, but any DSI project,
because the idea of DSI again is going back to the ethos
of connecting citizens and scientists together,
or like citizens and the science.
So if we could, you know, make that happen, kind of building those bridge and infrastructures and tools
to let that, you know, go forward.
This is the foundation, I feel. I have a dream that there's someday a pump science sort of platform for each and any indication you could think of.
It does.
That is still unsolved.
Yeah.
Awesome. So we have 10 more minutes. I would like to open up the stage for our audience.
Guys, please feel free to come up. You don't have to ask anything related to pump signs,
but like it would be general suggestion, feedback or any questions, criticisms, anything towards Desai. And we have Andreas here.
Andreas, do you have time to talk to us? Because I've been following your post and your poll,
which you ran, it came out that 40% of your respondents being Desai is not working.
40% of your respondents being visa is not working.
And would love to dig this along with you.
If you have time, if you could come up on stage,
I would really love to have this discussion
for the next 10 minutes.
I'm just gonna send you an invite to speak.
Yeah, feel free to accept our decline, but yeah.
I see another drug dev on the line as well.
So invite them to speak if they want to.
Yes, sending in right there.
But again, if not, me and Kehoe will just keep yapping as we always do yes um yeah
Colin did you did you see the poll that Andreas ran uh did you I did I answered it
yeah I saw your reply as well right like you guys were discussing on this yeah i like i like andreas's follow-up too
yeah i i really liked it um what do you what do you think in general right like
um it's a very small sample size but uh it's just like as andreas highlighted it's multi
it's multiple reasons one not getting enough light to shine about these projects that we are building or we are building
it um you know very silently we need to make some noise and all of that um what do you think like
i guess exactly what do you think is the top three uh takeaways sort of you know, for the next phase, knowing that this is the public perception of DSI, right?
Like, what are your plans specific to projects that you're working
or in general being in DSI for a year or so?
What do you think as, you know, angles that you could start expanding?
Yeah, so I think that a couple of like IPTs
that I'm working with now
are at a point when they've got some really exciting data.
And I think that finding a way to get that data
onto every platform so that people are talking about it,
I think is going to be a major point
for getting people to realize
that there is rubber meeting
the road. It's no longer the theoretical like funding into the void. Because I think that,
you know, people want to see that the dollars that they allocated are doing what it was said
it was supposed to do. I think people are even satisfied
when experiments don't work out,
but I think that there is possibly
a lot of very exciting, positive news
that's gonna be popping up for some of these studies soon
that I think will be sort of the,
that will push into a lot of the like mainstream media sources.
I can, I hope.
More attention. We need more attention on the space.
I think that the pump science launch is going to go really well tomorrow.
And that's going to be like the major diving point. And, you know, a little bit of secret alpha.
There's maybe some more tokens for launching sometime next month that I think will be even more positive attention toward the space.
People just aren't yet aware that we're cooking.
We just need to let them know we're cooking.
Cook out loud.
Exactly. Yeah. I think making, um,
noise really makes sense, you know, because, uh,
we need to bring more attention to decide. Um,
I think that's what, um,
next few months will be focused on, you know,
building that momentum for decide to
really start aping yep so to the audience if you if you guys want to come
up ask questions feel free to raise your hands send you an invite if it's not the case, then...
Andres, okay.
No, we have...
Hey, Andres, how you doing?
Hey, what's up, guys?
How are you guys?
Hey, doing well, man.
Great to hear from you.
You as well. you as well you as well i i saw you uh you were like a
drug def one of the new compounds yes sir yes sir bxb dropping tomorrow interesting interesting
it's gonna be yeah excited to see them all come out yeah it's it's definitely gonna be some
craziness it's been a it's been a few months in the making,
so I'm very excited to be launching finally.
Yeah, it seems like all the markets are getting much better.
If we can just have this sustained for a bit,
I think we can really fill up my attention.
Yeah, like based on the poll you guys were discussing
that I put out, yeah, I think there are some pretty important takeaways.
I think to me, the biggest things I know is just that,
first of all, I honestly don't think that most projects
are very good actually getting attention,
which I think is a big obstacle.
And I'm not saying it's easy, I think it's very hard.
But I think there's just a lot more expectation of that and try many different things.
And then, like, second of all, there's, I think overall also there's just not actually that much communication on even just the science happening the things happening um in the space it's like it's usually very sporadic updates on different different projects like even in all
these ipt's and stuff like i think like we're hearing something like every few months but like
it's encrypted doesn't really work to just hear something so slow like the the time frames are so
much shorter so like you're just waiting to have these big like data drops,
like in, in biotech,
like it doesn't really make sense because it's just,
it's not the same at all.
So I think like to me,
that's probably two of the most significant things that should be really
improved and could,
could be easily improved.
It was a lot more expectation on that end,
which,
which is kind of like,
I mean, it's kind of following the same playbook, in my opinion, which I think makes things difficult to then really realize if working or not and then kind of take the space to the next level.
And, of course, again, market dynamics matter a lot as well.
So that also means that we can actually get sustained uptrend.
We'll just, of course, see more attention coming in as well
so i i think those are probably the biggest takeaways at least on my end
yeah i definitely agree with you
yeah i i definitely think i think uh it has to do a lot with market but then
um sometimes i also think right like we are talking about market that's
that's bigger and greater like it's a trillion dollar market and we definitely are not gonna
influence that we are not like bitcoin or whatever but i think if we communicate well on what we are
building the message is sound enough and if we fine we fine tune to reach out to those audience and pique their interest and give
them something, you know, that is fun and enjoyable for them.
And also I read your comments, like comments on that particular poll on why it works and
why it doesn't work.
It really makes sense.
People in crypto are used to, you know, simple things and things that are tangible and usable.
But science, the process in itself being longer and riskier,
all of this kind of complicates the narrative.
But I think now is the time to really reshape that narrative,
is the time to really reshape that narrative um show that we can build something uh you know
things that are really tangible for people to use uh not just you know things that stays as an ip
or something but things that you can really put at use every day like ai agents uh trials supplements
trials, supplements, whatever, right?
I think these are actually like some places
where we can try to implement these
because I'm as an individual have a lot of questions around,
a lot of, you know, uncomfortness around products
that are sold to me, be it supplements or be it drug compounds and all of
that so having that clarity or like that sort of data that comports me to consume any drug or
supplement really is something that not just me a lot of people really wants to have. So I think starting with things
that are like people's daily life problems,
at least one of the top three burning issues
that people have and start solving for that
will really create that initial boost for DSi
and then bringing it with crypto elements,
making it more innovative, like, you know,
pump science or trying new sort of experimental models,
like citizen science experiments and stuff like that would add,
like, this new layer of DSi narrative to it.
Yeah.
Yeah, I really agree with the timeframe of everything too.
You know, if you think about a traditional biotech,
you're, you know, it takes you a decade to develop the,
you know, the therapeutic that, you know, you'll take to market.
But people in crypto, you know, we want these daily,
at least weekly, maybe every couple days sort of um
sort of updates and so that's where I really like pump science because the experiments have
you know on as they're ongoing they have literally like hourly updates so if you're someone who needs
your your telegram chat to be busting every hour on the hour, you know, that, that solves for that. But I think people perhaps need to build their build.
We talked about it last week, build backwards from their,
from their end goal a little bit more, I think in the D size space,
so that they can from the jump incorporate a consistent level of communication
that satisfies their, you know, crypto community,
while also, you know, not necessarily giving away too much or being one of those people who,
while the market's good, they're talking a lot. But when the market's bad, they're,
they're super silent, not really saying much. The continued like building out loud,
like we were saying, in even like a bear market, I think is really important for,
you know, people to maintain confidence in these projects
over a long period of time.
Yeah, I think you guys,
I'm losing some really good points there.
I think like, yeah, like first of all,
bridging the gap of the science to the user.
I think that's a big deal because yeah,
like the reason why some of these
projects they blow up is usually because you can actually use them and actually get some value from
them of course besides token price like but but basically those two are probably powerful things
that kind of remake things um things blow up i think they matter a lot if you can find a way to
actually make it usable to like the the normal user and get a lot if you can find a way to actually make it usable to the normal user.
You get a lot of people to actually care about it.
And then, yeah, what you were mentioning.
Wait, Carly, I completely forgot my mention of thought now.
Can you just mention the last thing you just said?
Yeah, I was talking about the time frame of it all.
How do you build for these long-term projects that you need for the biotech and therapeutic space while still maintaining consistent communication throughout the daily or weekly that you need to for a lot of different crypto projects?
daily or weekly that you need to for a lot of different crypto projects yeah yeah um yeah uh
that was another point that you kind of alluded to also because i yeah i agree with that but also
just that i think yeah one one mistake i'm also seeing like in the space and just many organizations
are making is that when the markets are down, they get completely quiet.
Yeah, that's, yeah.
Yeah, and then people kind of think they actually died.
Like the product is gone, especially in crypto where like things move so fast.
So if you don't hear anyone for like a few weeks or even months, which I've seen several
projects like this, these are basically communicating nothing or very, very little.
It's a very, it's a very bad thing.
And actually it's interesting because I've seen
in studies on these organizations overall
that actually have a lot more communication
and marketing in downturns,
they actually bounce back much harder
than the ones that are completely silent.
So I think it's like,
they're seeing these studies,
but I think it's like two to three X increase
in what they've kept after like the markets actually bounced back.
It just kept on being communicative and building fundamentals and actually showing they're still there while the things are down.
So they're kind of like fighting the gravity is kind of moving down, but you're still staying at a higher equilibrium than moving down with the markets.
So you're kind of like fighting that. You're actually able to then bounce back much stronger
than if you just are not actually active at all,
or very little.
So I think actually even that is a really powerful point
that really matters and everyone should be doing
that actually you should be a lot more loud
when things are down than up
if you actually want to get consistency.
That makes a lot of sense.
Yeah.
Yeah. If you think about like trauma bonding uh you you remember a lot more of the people that were there and talking to you when
you were having a bad time than the people that were only there for the good times right
yeah yeah and i think it's overall it was like also um when you're kind of thinking about like
the short-term narratives in crypto,
like people are talking a lot about scans and stuff.
And like, if you don't hear from a project
for just almost like a week or a few weeks,
it's like, it almost seems like people think it's a scam
because like, why are they just gone, you know?
So I think it's even more important in crypto
than other industries even.
And so Andrea, as you are here um do you have any alpha from elata for us since you are here uh would love to hear from what you guys are cooking and then we can close the call
yeah yeah for sure uh yeah yeah we have a lot of things moving.
We are basically upgrading our EEG right now to 32 channels.
So we are basically making the research there and the availability of that in the much high
quality.
So we're going to have initially these two different products there.
We're going to have 8 channel and 32 channel. that the hl is going to be very cheap and 32 is still going to be like cheap compared to other
um at that level but still a little more expensive because of course it's a high quality
and more like research grade um so that's that's like we're basically finalizing that very soon
and and yeah we're kind of we're actually getting really close um to our launch as well
so we're kind of like finalizing planning with all that as well finalizing different partnerships and
yeah just kind of like finalizing the timeline there and uh and getting all that into place
our like onto research protocol like sort it's also being like you know tested with the new uh
ui we're creating and everything.
So the things are really moving forward.
We are quite excited with everything.
And we're just basically finalizing the big things to really launch at a really good level with all the projects.
And I feel like everything is moving along.
These have to be a bit more uh positive the
markets are looking good um more excited um of course like the poll was still showing that
sentiment is still not the best yet but hopefully we'll see this improve uh over time we just keep
on pushing forward you know so so yeah like i i'm very optimistic about the future and i think
i think we're gonna see some really really cool things happening over the next few months.
Awesome.
Very exciting.
We keep pushing.
I will be glued to a lot of bios, Paige, too.
Need to know
the latest of the launches.
Love it.
Really want to commend you as well,
Andreas. You know, you don't just talk the talk
you're you walk the walk as a dsai um founder so we really appreciate you for bringing the energy
that we need to see in more people um and hopefully you know in the near future your
sentiments can be spread uh far and wide thank you so much appreciate that
thanks andreas for joining um he's definitely uh an inspiration to look at
and a good friend in dsai i really like um you know we are aligned in terms of, you know, ethos of what DSI should be or what could be, like how this could be revolutionary.
Like, you know, keep those boundaries, but also to expand, be experimental, be rational, be self-critical and all of that.
These are like, I think, good things to pick up and as like cardinal rules to
for builders in dsai um and i think uh andreas is one such person uh yeah really uh appreciate
you joining the call and i would yeah uh listeners if you if you want to if you are interested in
uh mental health and if you are affected by one or the other mental health issues and if you are interested in mental health and if you are affected by one or the other mental health issues,
and if you are looking for a solution or a community to lean to,
you should check out Elata Biosciences or Andreas's.
Just click away to your DM.
Please feel free to reach out to him.
All right.
Thanks, everyone, for tuning in.
And we are top of the hour.
And we also ran an additional 10 minutes
because we were late today.
Yeah, sorry for starting late.
Yeah.
Thanks, everyone, for joining for the next week,
T-Sci Office Hours. joining um for the next week these i office hours um just a reminder um pump science the platform
is launching tomorrow with a july 29 uh 8 eastern standard time uh i'm not sure what that is utc but
you know lock in on pump.science um that's where everything's going to be happening uh the telegram
is going to be busting if you have any questions about berberin or biotin, just at me directly or at the berberin
biotin page.
And, you know, thanks for listening to me yap about it all day today.
It's something that's been a few months in the making.
So very excited to finally be going up live and getting the results of all these experiments
out there.
So thanks for listening. We'll see you guys next week. See you guys next week. Bye-bye. Keep building. Love you.
